Exclusion Criteria:~* Early onset of dementia, i.e. before 60 years old to avoid hereditary AD forms~*
Significant neurological disease other than AD~* Major psychiatric disorder or syndrome (schizophrenia or
bipolar disorder)~* Seizure disorders~* Other infectious, metabolic or systemic diseases affecting central
nervous system~* Other active clinically significant illness~* Hospitalization or change of chronic concomitant
medications one month prior to screening~* Patients with severe respiratory, hepatic or renal failure or with
any other significantly potentially disabling abnormality detected during screening~* Known hypersensitivity to
the tested treatment including active substance and excipients.~* Patients participating in another study and
exposed to any investigational therapy within the 30 days prior to the entry in this study.~* Patient without
medical care insurance
